Volume | 547,937 |
|
|||||
News | - | ||||||
Day High | 1.34 | Low High |
|||||
Day Low | 1.27 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
SELLAS Life Sciences Group Inc | SLS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.28 | 1.27 | 1.34 | 1.32 | 1.29 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
2,950 | 547,937 | $ 1.30 | $ 713,133 | - | 0.4986 - 1.914 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:59:53 | 5 | $ 1.33 | USD |
SELLAS Life Sciences (SLS) Options Flow Summary
SELLAS Life Sciences Group Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
42.64M | 32.06M | - | 0 | -37.34M | -1.16 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
SELLAS Life Sciences News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SLS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.16 | 1.4399 | 1.12 | 1.29 | 2,672,976 | 0.16 | 13.79% |
1 Month | 1.47 | 1.72 | 1.12 | 1.37 | 1,714,686 | -0.15 | -10.20% |
3 Months | 0.7699 | 1.72 | 0.657 | 1.22 | 1,604,801 | 0.5501 | 71.45% |
6 Months | 0.94 | 1.72 | 0.4986 | 1.04 | 1,270,923 | 0.38 | 40.43% |
1 Year | 1.72 | 1.914 | 0.4986 | 1.09 | 780,136 | -0.40 | -23.26% |
3 Years | 7.70 | 15.0789 | 0.4986 | 3.04 | 454,586 | -6.38 | -82.86% |
5 Years | 0.971 | 19.38 | 0.1021 | 1.95 | 2,406,895 | 0.349 | 35.94% |
SELLAS Life Sciences Description
SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax. |